Abstract
Full text available
Current Bioactive Compounds
Title: Anti-Malarial
Volume: 1 Issue: 2
Author(s): Bentham Science Publishers
Affiliation:
Abstract: Full text available
Export Options
About this article
Cite this article as:
Bentham Science Publishers , Anti-Malarial, Current Bioactive Compounds 2005; 1 (2) . https://dx.doi.org/10.2174/1573407054985624
DOI https://dx.doi.org/10.2174/1573407054985624 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
9
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Could Targeting HMGB1 be Useful for the Clinical Management of COVID-19 Infection?
Combinatorial Chemistry & High Throughput Screening Histone Deacetylase Inhibitors: The Abbott Experience
Current Medicinal Chemistry Does Hypofractionated Radiotherapy Regimens Increase the Vulnerability to SARS- COV-2 by Influencing ACE-2 Activity?
Coronaviruses <i>In silico</i> Identification of Novel SARS-CoV-2 Main Protease and Nonstructural Protein 13 (nsp13) Inhibitors through Consensus Docking and Free Binding Energy Calculations
Combinatorial Chemistry & High Throughput Screening Monoamine Oxidase Inhibition and Molecular Modeling Studies of Piperidyl-thienyl and 2-Pyrazoline Derivatives of Chalcones
Medicinal Chemistry Hypersensitivity Reactions to Last Generation Chimeric, Umanized and Human Recombinant Monoclonal Antibodies for Therapeutic Use
Current Pharmaceutical Design High Throughput Screening for Drug Discovery and Virus Detection
Combinatorial Chemistry & High Throughput Screening Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the <i>“Cytokine Release (Storm) Syndrome”</i> Caused by SARS-CoV-2?
Current Pharmaceutical Design New Developments and Applications of Docking and High-Throughput Docking for Drug Design and in silico Screening
Current Computer-Aided Drug Design Bioactive Compounds Containing Benzoxadiazole, Benzothiadiazole, Benzotriazole
Current Bioactive Compounds Abscisic Acid: A Versatile Phytohormone in Plant Signaling and Beyond
Current Protein & Peptide Science A New 1,2,4-Triazole Acyclonucleosides: Synthesis and Biological Evaluation
Letters in Drug Design & Discovery The COVID-19 and Munchausen Syndrome
Coronaviruses 1,3,5-Triazine Analogs: A Potent Anticancer Scaffold
Current Signal Transduction Therapy Discovery of Novel CK2 Leads by Cross-Docking Based Virtual Screening
Medicinal Chemistry Bio Fabrication of Silver Nanoparticle from Argemone mexicana for the Control of Aedes albopictus and their Antimicrobial Activity
Current Pharmaceutical Biotechnology Computer-Aided Drug Design of Anti-inflammatory Agents Targeting Microsomal Prostaglandin E<sub>2</sub> Synthase-1 (mPGES-1)
Current Medicinal Chemistry Small Molecule Antagonists of the CXCR2 and CXCR1 Chemokine Receptors as Therapeutic Agents for the Treatment of Inflammatory Diseases
Current Topics in Medicinal Chemistry Structure-Activity Relationships of Glutamate Carboxypeptidase II (GCPII) Inhibitors
Current Medicinal Chemistry Prospecting for New Inhibitors of Anaplastic Lymphoma Kinase, A Clinically Relevant Oncogenic Drug Target
Current Bioactive Compounds